Navigation Links
Most embryos produced during IVF do not result in live births

Researchers at Yale School of Medicine have found that 85 percent of embryos transferred during in vitro fertilization fail to become live births, highlighting the need for improving diagnostic techniques to identify viable embryos.

Published in the August issue of Fertility and Sterility, the study reviewed seven years of U.S. statistics from all the fertility clinics that report data on reproductive techniques. Director of the Yale Fertility Center, Pasquale Patrizio, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences led the project.

"Something in nature has decided that these implanted embryos are not viable," said Patrizio, who conducted the study with co-author George Kovalevsky, M.D.

"We as practitioners in the reproductive clinic are in a paradoxical situation," Patrizio added. "There is pressure to reduce multiple births, but we need to do so knowing that the majority of the embryos that are transferred do not implant. It is difficult to strike a balance between these two needs."

Patrizio said he and his fellow physicians strive to better identify the embryos with the most potential. But addressing the growing pressure to transfer fewer embryos to reduce multiple births is a difficult task unless they can come up with a method in the lab to identify the best embryos.

"Some potential methods for screening embryos include using pre-implantation genetic diagnosis and biochemical markers of embryo viability," said Patrizio. "In addition this study should also move the field toward perfecting methods of egg production."


'"/>

Source:Yale University


Page: 1

Related biology news :

1. Scientists succeed in cloning human embryos from eggs matured in the lab
2. Changes to embryos can elicit change in adult fish
3. Forsyth scientists gain greater understanding of how embryos differentiate left from right
4. How IVF could be causing genetic errors in embryos
5. Successful transplantation from pig embryos to mice
6. Researchers report technique for freezing and preserving genetically enhanced pig embryos
7. Many couples choose to donate surplus embryos for stem cell research
8. Procedure predicts embryos most likely to result in pregnancy
9. Inexpensive, mass-produced genes core of synthetic biology advances at UH
10. Living taste cells produced outside the body
11. Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/6/2017)... 2017 Mintigo , the leader ... Predictive Sales Coach TM , its new artificial ... into Salesforce. This unique AI application will allow ... with deep knowledge of their customers and prospects ... Predictive Sales Coach extends Mintigo,s existing customer success ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen ... the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff ... of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, technology, ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
Breaking Biology Technology: